Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple Sclerosis
Clinical trial NCT04261790 · COMPLETED
Trial details
- NCT number
- NCT04261790
- Sponsor
- Johns Hopkins University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2024-10-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.